Tilray Brands Inc vs Vanguard International High Dividend Yield ETF — how do they compare? Tilray Brands Inc trades at $4.2 (market cap $577.15M), while Vanguard International High Dividend Yield ETF trades at $105.85. The key difference: Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| TLRY | VYMI | |
|---|---|---|
Market Cap | $577.15M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $21.00 | $107.13 |
52-Week Low | $3.88 | $82.92 |
Enterprise Value | $744.29M | — |
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $4.30, down 4.44% with a bearish technical outlook. The company reported record fiscal 2026 revenue of $915M but continues to post significant losses with a -13.27% net margin. Recent news highlights expansion in spirits distribution and medical cannabis production, though regulatory uncertainty weighs on sentiment. The stock trades below book value with a P/S of 0.51 and P/B of 0.36, suggesting potential undervaluation despite profitability challenges.
TLRY presents a high-risk opportunity with mixed signals. The discounted valuation and expanding beverage/alcohol business offer upside potential, but persistent losses, negative cash flow, and cannabis regulatory delays create substantial headwinds. Analyst consensus leans cautious with 65% hold ratings, reflecting the stock's speculative nature amid ongoing operational challenges.
VYMI trades at $106.2, down 0.78% on the day, with a bullish technical signal driven by moving averages. The ETF has gained attention for its international high-dividend yield strategy, outperforming U.S. counterparts in recent periods. Recent news highlights its appeal to retirees and institutional investors amid a weakening dollar, with a dividend of $1.26 scheduled for June 2026.
The outlook for VYMI is positive, supported by Vanguard's bullish stance on international developed markets and strong dividend growth. Risks include currency fluctuations and global economic volatility, but institutional accumulation and media optimism suggest continued interest for income-focused portfolios.
Trailing returns across standard periods
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →